Navigation Links
New Options Available for the 13 Million Men Who Suffer from Testosterone Deficiency
Date:9/1/2009

Although female hormone replacement has been the center of attention, male hormone levels are just as important to health and wellness. More men are getting tested and more treatment options are becoming available.

Dallas, TX (PRWEB) September 1, 2009 -- While all the news over the last decade seems to revolve around female hormones, more physicians are seeing the need to test and treat their male patients for testosterone deficiency. A new study suggests that as many as 13 million men may suffer from a deficiency of testosterone. Some physicians feel that the findings are consistent with more men asking for help. "The stigma associated with asking for help is gone. Some of this may be due to the increased drug advertisements targeted for men," states Dr. Anderson, MD of Executive Medicine of Texas

Testosterone deficiency is a serious problem and not only is associated with sexual dysfunction, but can also cause loss of muscle mass, weight gain, higher cholesterol levels, cardiovascular disease and other disorders. Patients with low testosterone levels may feel sluggish or depressed. Personal relationships can suffer too, due to the patient's lack of enthusiasm or interest.

Testosterone creams and injections have been in the mainstream of health care treatments and available to patients in the past. The good news is that the FDA announced the approval of the first long-acting Testosterone replacement treatment. Testopel® is manufactured by Slate Pharmaceuticals and is administered by a growing number of physicians. It consists of small pellets that are inserted under the skin just below the beltline during an in-office procedure. The procedure lasts only a few minutes and is done without sedation or stitches.

"Our patients are thrilled that we can do this procedure and they don't have to think about it again for up to six months." Walter Gaman, MD of Executive Medicine of Texas continues, "Since we are always looking for proven treatments to better help our patients, Testopel® is a welcome addition."

Dr. Gaman was one of the first physicians to offer this treatment within his practice, after it became FDA approved this year. The procedure is quick and easy, but does take a skilled physician to administer. Physicians administering the pellets should be properly instructed on administration and appropriate prescribing.

Executive Medicine of Texas is a leading provider in men's health and wellness. They treat executives and high profile individuals from around the globe and now offer Testopel® as an in-office procedure. The cost per insertion is $1200, which includes a three month testosterone blood level. Insertions can last up to six months, but blood tests can check to ensure that levels are remaining adequate, whereas small number of patients may metabolize the hormone faster requiring insertions to be repeated before the six month mark.

To schedule testing for testosterone deficiency or if you have documented deficiency and wish to schedule a Testopel® insertion, call (817) 552-4300 or (800) 910-EXEC. To learn more about Executive Medicine of Texas, visit http://www.emtexas.com. To learn more about Testopel®, visit http://www.testopel.com.

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2815284.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Georgia Reproductive Specialists Free Infertility Seminar: Fertility Options 101
2. ValueOptions(R) Awards Coordination of Benefits and Overpayment Services Contract to HMS
3. Blue Cross and Blue Shield Association Introduces Interactive Navigation Solution That Helps Individuals and Families Find Healthcare Coverage Options
4. Commercial Real Estate Group of Tucson Unveils Online Tool that Quickly Informs Commercial Real Estate Tenants of Lease Options
5. FREE INFERTILITY SEMINAR: Fertility Options 101
6. ValueOptions Wins Maryland Mental Health Contract
7. Pennsylvanians With Disabilities Call for an End to Institution-Only Options
8. TCS Healthcare Technologies to Offer Remote Hosting Options for Acuity Advanced Care(TM)
9. Health Insurance Options for Domestic Partnerships
10. 'Comparative Effectiveness' Research Addresses Options for Treating Prostate Cancer
11. Hybrid Concierge Medical Practice Provides More Value, Options to Growing Number of Physicians Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Options Available for the 13 Million Men Who Suffer from Testosterone Deficiency
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, 2016 ... Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, the ... announced today online at www.diabetesscholars.org by the ... diabetes stand in the way of academic and community ... Foundation,s scholarship program since 2012, and continues to advocate ...
Breaking Medicine Technology: